Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06061588
Other study ID # Virtual Reality in Migraine
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2023
Est. completion date March 10, 2024

Study information

Verified date May 2024
Source Ankara City Hospital Bilkent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this research is to investigate the effects of virtual reality technology on the treatment of migraine-type headaches and assess how this technology may impact the severity, frequency, and duration of headaches.


Description:

This is a non-randomized controlled prospective study with the primary objective of investigating the effects of virtual reality technology on the treatment of migraine-type headaches and assessing how this technology can potentially influence the severity, frequency, and duration of headaches. Additionally, the study aims to analyze the impact of virtual reality technology on the neurological and psychological components of headaches, evaluate potential improvements in the quality of life for migraine patients undergoing virtual reality therapy, monitor the long-term effects of virtual reality in migraine treatment, and assess its sustainability. The study is divided into two arms, labeled as Arm 1 and Arm 2, with randomization being carried out by the principal investigator. All patients consenting to participate in the study will receive a standard treatment of 150 cc normal saline containing arveles (50 mg dexketoprofen), and no patient will be left untreated. One group will receive only the standard treatment (control group), while the other group will receive both the standard treatment and, in addition, virtual reality therapy consisting of a virtual environment simulating moonlight by the dark seaside or a campfire ambiance with classical music (calm, slow, and soothing) using virtual reality goggles. Prior to medication administration (0.min) and at 15, 30, 60, and 120 minutes, patients' VAS scores will be recorded. Adult patients diagnosed with migraines who have agreed to participate in the study will be included. Patients will be eligible to participate in the study if they meet specific inclusion criteria. The severity of pain in patients diagnosed with migraines and the effectiveness of treatments used for migraine attacks will constitute the dependent variables of the study.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date March 10, 2024
Est. primary completion date March 10, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - 18 years of age or older - Under the age of 65 - Willing to participate in the study - Previously diagnosed with migraine - Marking a VAS score of 50 or higher - Not considered for any additional preliminary diagnosis - No known adverse history to the active ingredient of the medication to be used - Conscious - Cooperatively oriented Exclusion Criteria: - Under 18 years of age or over 65 years of age - Not willing to participate in the study - Displaying vital signs outside of normal limits - With a known history of adverse reactions to NSAIDs - Unable to determine the severity of pain on the VAS - Scoring 50 mm or lower on the VAS - Pregnant individuals - Individuals with advanced systemic illness - Those with malignancies - Patients with chronic liver and kidney disease - Using sedative and analgesic neuro-psychiatric drugs - With a history of psychological and neurological diseases - Having taken analgesics within 8 hours prior to examination

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual Reality
The use of virtual reality as an adjunct to routine treatment.

Locations

Country Name City State
Turkey Ankara City Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

References & Publications (6)

Almedhesh SA, Elgzar WT, Ibrahim HA, Osman HA. The effect of virtual reality on anxiety, stress, and hemodynamic parameters during cesarean section: A randomized controlled clinical trial. Saudi Med J. 2022 Apr;43(4):360-369. doi: 10.15537/smj.2022.43.4.20210921. — View Citation

Bagher SM, Felemban OM, Alandijani AA, Tashkandi MM, Bhadila GY, Bagher AM. The effect of virtual reality distraction on anxiety level during dental treatment among anxious pediatric patients: a randomized clinical trial. J Clin Pediatr Dent. 2023 Jul;47(4):63-71. doi: 10.22514/jocpd.2023.036. Epub 2023 Jul 3. — View Citation

Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study. Cephalalgia. 1994 Aug;14(4):297-300. doi: 10.1046/j.1468-2982.1994.1404297.x. — View Citation

Genc H, Korkmaz M, Akkurt A. The Effect of Virtual Reality Glasses and Stress Balls on Pain and Vital Findings During Transrectal Prostate Biopsy: A Randomized Controlled Trial. J Perianesth Nurs. 2022 Jun;37(3):344-350. doi: 10.1016/j.jopan.2021.09.006. Epub 2022 Apr 7. — View Citation

Stepien A, Kozubski W. [Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks]. Wiad Lek. 2004;57(3-4):135-9. Polish. — View Citation

Yavuz E, Gulacti U, Lok U, Turgut K. Intravenous metoclopramide versus dexketoprofen trometamol versus metoclopramide+ dexketoprofen trometamol in acute migraine attack in the emergency department: A randomized double-blind controlled trial. Am J Emerg Med. 2020 Nov;38(11):2254-2258. doi: 10.1016/j.ajem.2020.04.038. Epub 2020 Apr 15. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale The change in patients' pain conditions with treatment. The pain is determined using a 100 mm scale. Patients are instructed to mark the level of pain they experience, with 0 mm indicating no pain and 100 mm indicating the presence of maximum pain. 0. -15. -30.-60.-120. minutes
Primary Rescue analgesic use For patients with a VAS score 50mm or higher at 120.minute rescue therapy was planned. 120.minute
Secondary Side effects The difference between two groups observed in terms of side effects were recorded. 120.minute
See also
  Status Clinical Trial Phase
Completed NCT05720819 - Biofeedback-VR for Treatment of Chronic Migraine N/A
Recruiting NCT05547152 - Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis N/A
Recruiting NCT05528497 - Assessment of the Influence of the Virtual Reality Headset on Pain and Anxiety During Oocyte Retrieval Under Local Anesthesia N/A
Recruiting NCT05378581 - Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children N/A
Completed NCT04091659 - Use of Virtual Reality for Overdose Management Educational Trainings N/A
Completed NCT04880486 - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT05982457 - The Effect of Virtual Reality Application in Cervical Dilatation and Effacement Teaching N/A
Completed NCT06112600 - The Impact of Virtual Reality and Kaleidoscope in Children During Vaccination N/A
Active, not recruiting NCT04532866 - Brain Changes in Response to Long-Duration Isolation and Confinement N/A
Completed NCT05604924 - Virtual Reality Training Simulator for Cesarean Section N/A
Recruiting NCT04736888 - Effectiveness of Extended Reality CPR Training Methods N/A
Not yet recruiting NCT05941390 - Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures N/A
Completed NCT05961033 - The Effects of Virtual Reality Based Exercises in Patients With Adhesive Capsulitis
Recruiting NCT04630184 - A Virtual Reality Exposure Intervention on Social Physical Anxiety in Women With Obesity N/A
Terminated NCT03665233 - Virtual Reality for Post Operative Pain Management After Total Knee Arthroplasty N/A
Recruiting NCT03698526 - Virtual Reality for Symptoms Control in Palliative Care N/A
Suspended NCT03715400 - Mobile Virtual Positive Experiences for Anhedonia N/A
Completed NCT03208400 - Virtual Reality Exposure in Spider Phobia N/A
Completed NCT05078762 - Immersive Virtual Reality in Simulation-based Bronchoscopy Training N/A
Completed NCT04014998 - Effectiveness of Virtual Reality in Patients With Chronic Neck Pain N/A